Alglucosidase Alfa

Drug Index

Alglucosidase alfa, sold under the brand name Myozyme among others, is an enzyme replacement therapy (ERT) orphan drug for treatment of Pompe disease (Glycogen storage disease type II), a rare lysosomal storage disorder (LSD).[4] Chemically speaking, the drug is an analog of the enzyme that is deficient in patients affected by Pompe disease, alpha-glucosidase. It is the first drug available to treat this disease.[2] It was approved for medical use in the United...

Alglucosidase Alfa

Alglucosidase alfa, sold under the brand name Myozyme among others, is an enzyme replacement therapy (ERT) orphan drug for treatment of Pompe disease (Glycogen storage disease type II), a rare lysosomal storage disorder (LSD).[4] Chemically speaking, the drug is an analog of the enzyme that is deficient in patients affected by Pompe disease, alpha-glucosidase. It is the first drug available to treat this disease.[2] It was approved for medical use in the United...

Alglucosidase Alfa

Alglucosidase alfa, sold under the brand name Myozyme among others, is an enzyme replacement therapy (ERT) orphan drug for treatment of Pompe disease (Glycogen storage disease type II), a rare lysosomal storage disorder (LSD).[4] Chemically speaking, the drug is an analog of the enzyme that is deficient in patients affected by Pompe disease, alpha-glucosidase. It is the first drug available to treat this disease.[2] It was approved for medical use in the United...

NDC Database

Myozyme 5 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution by Genzyme Corporation ## Package Codes: 58468-0150-1 ## Active Ingredients: Alglucosidase Alfa

NDC Database

Lumizyme 5 mg/ml Intravenous Injection, Powder, for Solution by Genzyme Corporation ## Package Codes: 58468-0160-1, 58468-0160-2 ## Active Ingredients: Alglucosidase Alfa